a. Committee -- Attending physician and at least one attending nurse from shift; head physician of HR; ER administrator; representative from HR; representative from Legal; Union representative (if appropriate); PR representative; potentially GP depending on hospital relationship and legal vulnerability.

b. Testing of interventions -- likely establishment of at least two new protocols would be put in place; 1) heightened diligence and/or special considerations for certain pharmaceutical combinations with concurrent educational seminars and/or training sessions; 2) additional monitoring criteria based on patient history, combination of symptoms, severity of treatment. Impossible to do double blind studies on these implications, because a repeat of the action is not wanted; but using case analysis and review, potential negative outcomes could still be tested appropriately.

c. Pre-Steps for FMEA Preparation:

a. Collection and analysis of patient records during ER visit.

b. Collection and analysis of patient file from GP or previous hospital visits.

c....
[ View Full Essay]